Cargando…

Pragmatic trials: ignoring a mediator and adjusting for confounding

OBJECTIVES: In pragmatic trials, the new treatment is compared with usual care (heterogeneous control arm) that makes the comparison of the new treatment with each treatment within the control arm more difficult. The usual assumption is that we can fully capture the relations between different quant...

Descripción completa

Detalles Bibliográficos
Autor principal: Pericleous, Paraskevi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425675/
https://www.ncbi.nlm.nih.gov/pubmed/30894221
http://dx.doi.org/10.1186/s13104-019-4188-1
_version_ 1783404884831240192
author Pericleous, Paraskevi
author_facet Pericleous, Paraskevi
author_sort Pericleous, Paraskevi
collection PubMed
description OBJECTIVES: In pragmatic trials, the new treatment is compared with usual care (heterogeneous control arm) that makes the comparison of the new treatment with each treatment within the control arm more difficult. The usual assumption is that we can fully capture the relations between different quantities. In this paper we use simulation to assess the performance of statistical methods that adjust for confounding when the assumed relations are not true. The true relations contain a mediator and heterogeneity with or without confounding, but the assumption is that there is no mediator and that confounding and heterogeneity are fully captured. The statistical methods that are compared include multivariable logistic regression, propensity score, disease risk score, inverse probability weighting, doubly robust inverse probability weighting and standardisation. RESULTS: The misconception that there is no mediator can cause to misleading comparative effectiveness of individual treatments when a method that estimates the conditional causal effect is used. Using a method that estimates the marginal causal effect is a better approach, but not for all scenarios. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13104-019-4188-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6425675
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64256752019-04-01 Pragmatic trials: ignoring a mediator and adjusting for confounding Pericleous, Paraskevi BMC Res Notes Research Note OBJECTIVES: In pragmatic trials, the new treatment is compared with usual care (heterogeneous control arm) that makes the comparison of the new treatment with each treatment within the control arm more difficult. The usual assumption is that we can fully capture the relations between different quantities. In this paper we use simulation to assess the performance of statistical methods that adjust for confounding when the assumed relations are not true. The true relations contain a mediator and heterogeneity with or without confounding, but the assumption is that there is no mediator and that confounding and heterogeneity are fully captured. The statistical methods that are compared include multivariable logistic regression, propensity score, disease risk score, inverse probability weighting, doubly robust inverse probability weighting and standardisation. RESULTS: The misconception that there is no mediator can cause to misleading comparative effectiveness of individual treatments when a method that estimates the conditional causal effect is used. Using a method that estimates the marginal causal effect is a better approach, but not for all scenarios. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13104-019-4188-1) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-20 /pmc/articles/PMC6425675/ /pubmed/30894221 http://dx.doi.org/10.1186/s13104-019-4188-1 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Note
Pericleous, Paraskevi
Pragmatic trials: ignoring a mediator and adjusting for confounding
title Pragmatic trials: ignoring a mediator and adjusting for confounding
title_full Pragmatic trials: ignoring a mediator and adjusting for confounding
title_fullStr Pragmatic trials: ignoring a mediator and adjusting for confounding
title_full_unstemmed Pragmatic trials: ignoring a mediator and adjusting for confounding
title_short Pragmatic trials: ignoring a mediator and adjusting for confounding
title_sort pragmatic trials: ignoring a mediator and adjusting for confounding
topic Research Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425675/
https://www.ncbi.nlm.nih.gov/pubmed/30894221
http://dx.doi.org/10.1186/s13104-019-4188-1
work_keys_str_mv AT pericleousparaskevi pragmatictrialsignoringamediatorandadjustingforconfounding